Literature DB >> 15827772

The indications for and the prognostic significance of amputation as the primary surgical procedure for localized soft tissue sarcoma of the extremity.

Michelle A Ghert1, Adesegun Abudu, Natasha Driver, Aileen M Davis, Anthony M Griffin, Dawn Pearce, Lawrence White, Brian O'Sullivan, Charles N Catton, Robert S Bell, Jay S Wunder.   

Abstract

BACKGROUND: The indications for primary amputation of a localized soft tissue sarcoma (STS) of the extremity are not well defined in the literature. However, it has been suggested that patients who require an amputation to treat an STS are at increased risk for developing metastases. We categorized the main indications for primary amputation in our patient population and compared their oncological outcome with the outcome of patients who underwent limb-sparing surgery.
METHODS: 413 consecutive patients treated surgically at a single center for primary, nonmetastatic, deep, intermediate-, or high-grade STS of the extremity were reviewed. Indications for primary amputation were identified. Demographics and outcomes were compared between the amputation and limb-salvage groups. Multivariate Cox model analysis was used to identify independent risk factors for systemic relapse.
RESULTS: Twenty-five (6%) of 413 patients with STS underwent primary amputation: they were older (P = .05), had larger tumors (P = .001), and had a significantly greater risk of developing metastatic disease than patients who underwent limb-sparing procedures (P = .008). However, multivariate analysis demonstrated that the only independent predictors of systemic relapse were tumor size (P = .0001) and tumor grade (P = .0001). Primary amputation was not an independent risk factor for metastatic disease.
CONCLUSIONS: The decision to perform a primary amputation for an STS of the extremity is based on the location and local extent of the tumor, and the expected function of the extremity after tumor resection. The higher risk of metastases for patients who require primary amputation is accounted for by independent risk factors associated with their tumors--predominantly large tumor size.

Entities:  

Mesh:

Year:  2004        PMID: 15827772     DOI: 10.1007/s10434-004-1171-3

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  16 in total

1.  Case series. Soft-tissue sarcoma of the foot.

Authors:  L Daniel Latt; Robert E Turcotte; Marc H Isler; Cynthia Wong
Journal:  Can J Surg       Date:  2010-12       Impact factor: 2.089

2.  Soft tissue sarcoma clinical practice guidelines in oncology.

Authors:  George D Demetri; Laurence H Baker; Derrick Beech; Robert Benjamin; Ephraim S Casper; Ernest U Conrad; Thomas F DeLaney; David S Ettinger; Martin J Heslin; Ray J Hutchinson; Krystyna Kiel; William G Kraybill; G Douglas Letson; James Neff; Richard J O'Donnell; I Benjamin Paz; Raphael E Pollock; R Lor Randall; Karen D Schupak; Douglas S Tyler; Margaret von Mehren; Jeffrey Wayne
Journal:  J Natl Compr Canc Netw       Date:  2005-03       Impact factor: 11.908

3.  Sociooccupational and physical outcomes more than 20 years after the diagnosis of osteosarcoma in children and adolescents: limb salvage versus amputation.

Authors:  Giulia Ottaviani; Rhonda S Robert; Winston W Huh; Shana Palla; Norman Jaffe
Journal:  Cancer       Date:  2013-07-31       Impact factor: 6.860

4.  Local recurrence after initial multidisciplinary management of soft tissue sarcoma: is there a way out?

Authors:  Sarantis Abatzoglou; Robert E Turcotte; Abdurahman Adoubali; Marc H Isler; David Roberge
Journal:  Clin Orthop Relat Res       Date:  2010-11       Impact factor: 4.176

5.  The role of plastic surgery in sarcoma treatment.

Authors:  Juan María Viñls Viñals; Diana Pérez Sidelnikova; José María Serra Payro; José Antonio Palacín Porte; Anna Belén López Ojeda; Mari Carmen Higueras Suñe; Javier García del Muro; Alicia Lozano Borbalas; Frederic Portabella Blavia; Francisco Javier Sanjuán Garriga; José Antonio Narváez García
Journal:  Clin Transl Oncol       Date:  2011-02       Impact factor: 3.405

6.  Liposarcoma of the forearm in a man with type 1 neurofibromatosis: a case report.

Authors:  Markus Dietmar Schofer; Mohammed Yousef Abu-Safieh; Jürgen Paletta; Susanne Fuchs-Winkelmann; Bilal Farouk El-Zayat
Journal:  J Med Case Rep       Date:  2009-04-29

7.  Retrospective study of the surgical management and outcome of nonrhabdomyosarcoma soft tissue sarcomas of the groin and axilla in children.

Authors:  Gideon Karplus; Matthew J Krasin; Carlos Rodriguez-Galindo; Beth McCarville; Jesse Jenkins; Bhaskar Rao; George Spyridis; Sheri L Spunt
Journal:  J Pediatr Surg       Date:  2009-10       Impact factor: 2.545

8.  Segmental resection and replantation have a role for selected advanced sarcomas in the upper limb.

Authors:  Soo Bong Hahn; Yun Rak Choi; Ho Jung Kang; Kyoo Ho Shin
Journal:  Clin Orthop Relat Res       Date:  2009-05-02       Impact factor: 4.176

Review 9.  Multidisciplinary management of soft tissue sarcoma.

Authors:  Lukas M Nystrom; Nickolas B Reimer; John D Reith; Long Dang; Robert A Zlotecki; Mark T Scarborough; C Parker Gibbs
Journal:  ScientificWorldJournal       Date:  2013-07-28

10.  The vascularized fibular graft in the pediatric upper extremity: a durable, biological solution to large oncologic defects.

Authors:  Nicki Zelenski; Brian E Brigman; L Scott Levin; Detlev Erdmann; William C Eward
Journal:  Sarcoma       Date:  2013-10-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.